Living fillings: the future of regenerative dentistry?

August 17, 2023

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

January 14, 2023

Pfizer and Valneva Report Phase 3 Lyme Vaccine Miss but Plan Regulatory Filings

March 24, 2026

Must Read

Top 10 Reasons Omnichannel Engagement Still Falls Short in Healthcare

June 4, 2026

After FDA takes firm stance on safety hazards, Fulcrum discontinues the SCD program and explores other options

June 4, 2026

Subtle Medical Gets $33M Series C Funding, Appoints New CEO

June 4, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Early research shows that Lilly’s Verve strategy is successful in lowering cholesterol

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Phase 3 Trial Shows Obefazimod Achieves Clinical Remission in Ulcerative Colitis Patients

After a phase 2 failure, Biogen ends Parkinson’s prospects with Denali

Kelun Reports Positive Phase 3 Results for sac-TMT With Keytruda in First-Line NSCLC

Eli Lilly’s VERVE-102 Shows Up to 62% LDL Cholesterol Reduction in Early Trial

Subtle Medical Gets $33M Series C Funding, Appoints New CEO

For CAR-T biotech InnocsAI, struggling Liminatus pays $320 million in equity

Lilly Pens $3.8B Deal to Purchase 3 Vaccine Developers Amidst M&A Spree

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Reasons Omnichannel Engagement Still Falls Short in Healthcare

AI in Medical Affairs: How Pharma Is Becoming a Real-Time Scientific Intelligence System

Are Pharmaceutical Companies Moving Too Fast With AI Adoption?

From Pilots to Scale: Why Most Healthcare AI Projects Stall

Editorial Team

Subtle Medical Gets $33M Series C Funding, Appoints New CEO

Editor Picks

Living fillings: the future of regenerative dentistry?

Fate, Century, and TCR2 Therapeutics make major cuts to staff and research

Pfizer and Valneva Report Phase 3 Lyme Vaccine Miss but Plan Regulatory Filings

Must Read

Top 10 Reasons Omnichannel Engagement Still Falls Short in Healthcare

After FDA takes firm stance on safety hazards, Fulcrum discontinues the SCD program and explores other options

Subtle Medical Gets $33M Series C Funding, Appoints New CEO

Hot Topics

About Us

Follow Us